Safety and efficacy of new TKIs in Ph+ ALL VJHemOnc – Video Journal of Hematology & HemOnc 1:17 2 years ago 41 Далее Скачать
Recent advances in the treatment of Ph+ ALL and the important role of TKIs VJHemOnc – Video Journal of Hematology & HemOnc 2:55 2 years ago 73 Далее Скачать
New approaches to upfront therapy in Ph+ ALL VJHemOnc – Video Journal of Hematology & HemOnc 2:10 4 weeks ago 43 Далее Скачать
Treatment options for Ph+ ALL VJHemOnc – Video Journal of Hematology & HemOnc 5:23 4 years ago 599 Далее Скачать
Efficacy and safety of vodobatinib by lines of TKI therapy in Ph+ CML: a subgroup analysis VJHemOnc – Video Journal of Hematology & HemOnc 3:03 2 years ago 93 Далее Скачать
Update on the efficacy and safety of tyrosine kinase inhibitors for chronic myeloid leukemia VJHemOnc – Video Journal of Hematology & HemOnc 2:03 9 years ago 183 Далее Скачать
ASH 2024: Bijal Shah, MD Presents on the Blinatumomab + Ponatinib Effective in Ph+ ALL & CML Moffitt Cancer Center 1:04 4 weeks ago 47 Далее Скачать
Evaluating the safety of TKI discontinuation in adult patients with Ph+ ALL not undergoing alloSCT VJHemOnc – Video Journal of Hematology & HemOnc 1:48 1 month ago 67 Далее Скачать
Next generation TKIs for Ph+ ALL VJHemOnc – Video Journal of Hematology & HemOnc 2:15 3 years ago 165 Далее Скачать
TKI use in Ph+ and Ph-like ALL VJHemOnc – Video Journal of Hematology & HemOnc 1:34 3 years ago 250 Далее Скачать
Ponatinib & blinatumomab for Ph+ ALL VJHemOnc – Video Journal of Hematology & HemOnc 2:31 1 year ago 583 Далее Скачать
The evolution of treatment of Ph+ ALL & Phase II study of blinatumomab and ponatinib in Ph+ ALL VJHemOnc – Video Journal of Hematology & HemOnc 9:21 2 years ago 979 Далее Скачать
Current and emerging treatment options for Ph-like ALL VJHemOnc – Video Journal of Hematology & HemOnc 1:50 1 year ago 215 Далее Скачать
Efficacy & tolerability of available TKI therapies in CML & managing TKI resistance VJHemOnc – Video Journal of Hematology & HemOnc 6:22 2 years ago 68 Далее Скачать
Ponatinib, venetoclax and dexamethasone in R/R Ph+ ALL VJHemOnc – Video Journal of Hematology & HemOnc 2:57 3 years ago 73 Далее Скачать
Optimizing treatment for Ph+ ALL: TKIs combined with chemotherapy followed by transplantation VJHemOnc – Video Journal of Hematology & HemOnc 0:58 3 months ago 75 Далее Скачать
Can alloHSCT be avoided in Ph+ ALL? VJHemOnc – Video Journal of Hematology & HemOnc 0:52 2 years ago 70 Далее Скачать
Vodobatinib in patients with CP-CML who have received ≥ 3 prior TKIs including ponatinib VJHemOnc – Video Journal of Hematology & HemOnc 1:03 2 years ago 159 Далее Скачать
Could asciminib be the new breakthrough in the treatment of CML? VJHemOnc – Video Journal of Hematology & HemOnc 2:42 1 month ago 129 Далее Скачать
